Prescription Clones
The same prescription is being reused months later in your network — and every individual transaction looks perfectly normal.
This Pattern Is in Your Data Right Now
Here is what it looks like: a patient presents the exact same medications, the same quantities, from the same prescriber — but months after the original dispensing. The exact same 4-drug insulin combination appears in February, April, and June, from the same doctor, for the same patient.
Each individual transaction appears perfectly normal. The medications are legitimate, the prescriber exists, the quantities are reasonable. But the underlying pattern tells a different story.
Traditional systems that evaluate each transaction in isolation cannot detect this. Every dispense passes standard validations — valid coverage, active prescriber, formulary-listed drug. Only when the full patient history is analyzed does the pattern emerge.
This pattern can indicate medication diversion, where dispensed drugs are resold on the informal market, or simply abuse of the pharmaceutical reimbursement system. In either case, the insurer pays for medications that never benefit the patient.
What We Detect
Inspector AI identifies prescriptions that share the exact same medication combination, from the same prescriber, resubmitted in a later period. These are not similar prescriptions — they are identical medication lists presented as if they were new.
Our analysis looks for repetition patterns that would be impossible to identify by reviewing individual transactions. When the same precise medication combination appears repeatedly at regular intervals, this suggests a prescription template is being reused rather than the doctor evaluating the patient and issuing a new prescription.
It is important to note that we do not reveal the specific algorithms we use for this detection. What we can say is that the system is capable of identifying these cloning patterns even when they are presented at different pharmacies or with minor variations in dates.
This type of detection requires a longitudinal view of each patient and prescriber's history — something that transactional authorization systems simply cannot offer.
Why It Matters
Cloned prescriptions represent a behavioral fraud risk that, while smaller in financial volume than other patterns, has significant implications. Each dispense based on a cloned prescription is potentially medication diversion — drugs that never reach the patient.
In our analysis of Latin American health insurance claims, we identified this pattern with a median of $26 per transaction. While the per-transaction figure may seem modest, the systematic repetition — month after month — accumulates significant impact.
Beyond the financial cost, cloned prescriptions are a signal of organized fraudulent behavior. Identifying them early can reveal networks of pharmacies or prescribers participating in broader system abuse schemes.
$26
Median per transaction
$8K/yr
Annual projection per 50K subscribers
Discover If Your Data Shows This Pattern
We'll load a sample of your data into Inspector AI and show you if cloned prescriptions are repeating in your network. Free analysis, no commitment.
Request Free Analysis